Related Experiment Video
Updated: Jul 15, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort
Hiroshi Okamoto1, Kyoko Koizumi, Shigeo Kamitsuji
1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan. hokamoto@ior.twmu.ac.jp
Insights
Statins may reduce rheumatoid arthritis (RA) disease activity. This observational study found lower C-reactive protein and fewer swollen joints in RA patients taking statins, suggesting a beneficial role in rheumatology practice.
Area of Science:
- Rheumatology
- Pharmacology
- Clinical Research
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and potential systemic effects.
- Statins, primarily used for cholesterol management, are being investigated for potential anti-inflammatory properties.
- Understanding the impact of commonly prescribed medications on RA disease activity is crucial for patient management.
Purpose of the Study:
- To investigate the association between statin use and disease activity in patients with rheumatoid arthritis (RA).
- To analyze whether statins offer beneficial effects on RA disease markers in a large observational cohort.
Main Methods:
- Analysis of cross-sectional data from 4152 RA patients within the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) prospective observational cohort.
- Comparison of disease activity markers (C-reactive protein, swollen joint counts, patient/physician assessments) between statin users and non-users.
- Statistical analysis, including Mann-Whitney U-test, with adjustments for corticosteroid use.
Main Results:
- 6.7% of RA patients (279/4152) were taking statins.
- Statin users exhibited significantly lower C-reactive protein levels (0.85 vs 1.24 mg/dl) and fewer swollen joint counts (1.80 vs 2.55) compared to non-users.
- Even after adjusting for corticosteroid dosage, statin use was associated with lower RA disease activity across multiple assessment measures.
Conclusions:
- The findings suggest that statins possess beneficial effects in mitigating rheumatoid arthritis disease activity.
- Statin therapy may be a valuable adjunct in the management of RA patients in routine rheumatology care.
- Further research could explore the mechanisms underlying statins' anti-inflammatory effects in RA.
Objective:
To analyze the possible beneficial effects of statins on the disease activity of patients with rheumatoid arthritis (RA) using a database from a large observational cohort study.
Methods:
We studied a total of 7512 patients enrolled in a single-institute based prospective observational cohort of RA patients (IORRA); their information was collected biannually. In this study, cross-sectional data of 4152 patients (female 83.3%, average age 58.4 yrs) in October 2003 were analyzed (Mann-Whitney U-test).
Results:
Among 4152 patients with RA, 279 (6.7%) were taking statins; patients taking statins had lower C-reactive protein (0.85 vs 1.24 mg/dl, respectively) and lower swollen joint counts (1.80 vs 2.55), but more frequently used corticosteroids (2.88 vs 2.40 mg/day) compared to patients not taking statins. Serum cholesterol level was closely related to the use of corticosteroids. Thus, an adjustment with the dose of corticosteroid was conducted; even taking account of the effects of steroids, RA disease activity indicated by patient's assessment for pain, physician's assessment, and swollen joint counts was significantly lower in patients with statins compared to those without.
Conclusion:
This study indicates that statins have beneficial effects in reducing RA disease activity in the daily practice of rheumatology.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies